EU grants patent to Pulmatrix By: MarketMinute.com Stock News March 21, 2017 at 18:16 PM EDT The European Union granted Pulmatrix Inc. (Nasdaq: PULM) a patent for its inhaled drug delivery technology iSPERSE sending the stock price soaring $1.10 to close at $3.88. Related Stocks: Pulmatrix Inc